June 9, 2022
FDA: Class I recall of Medtronic HVAD Pump Implant Kit
Editor's Note
The Food and Drug Administration (FDA) on June 8 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) Pump Implant Kit as Class I, the most serious. The HVAD System is used as a bridge to cardiac transplants.
The Kit was recalled because of a pump weld defect that may cause the pump to rotate incorrectly. If this occurs, it may lead to pump malfunction, death, severe injury, or major surgery to replace the pump.
To date, there have been 3 complaints, 1 death, and 2 injuries. Distribution dates were October 11, 2006, to June 3, 2021.
Free Daily News
- Study: Preoperative stereotactic radiosurgery shows promise in brain metastases management
- Senate report: Private equity endangers patient care in underserved hospitals
- Study: Postoperative thirst often overlooked by OR, ward nurses
- FDA draft guidance addresses pulse oximeter accuracy, AI devices
- AAMI updates sterilization materials compatibility guidance
- Study: Esophagectomy outcomes worse at private equity hospitals
- Study: Black CABG patients disadvantaged in accessing best hospitals
- Health system to pilot AI-powered OR cameras; leaders acknowledge privacy challenges
- 3D modeling advances cardiovascular surgery at Boston Children's Hospital
- Report: Healthcare ransomware compromises millions of patient records, costs billions in downtime
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement